Explore the categories so you can find more about your search.
Categorie > Muscular Dystrophy
Clive Svendsen Of Cedars-Sinai To Receive ALS Research Award From American Academy Of Neurology
Categorie : Muscular DystrophyClive Svendsen, Ph.D., director of the Cedars-Sinai Regenerative Medicine Institute, is receiving the American Academy of Neurology Sheila Essey Award for his research on ALS (amyothrophic lateral sclerosis). ALS, often referred to as Lou Gehrig's disease, is a progressive neurodegenerative disease ...
read more 
Fri Mar 2010
Sandra Gidley MP Flexes Political Muscle To Call For New Muscle Disease Care Advisor, UK
Categorie : Muscular DystrophySandra Gidley MP is backing the fight for better muscle disease healthcare in Hampshire by calling on NHS bosses to fund specialist staff. Last month the South Central Muscle Group, a patients' forum for families in the region living with muscular dystrophy, met in Southampton where MP for Romsey S ...
read more Fri Mar 2010
Diary Note: Nottingham Muscle Group Meeting, UK
Categorie : Muscular DystrophyWhat Families affected by muscle disease in Nottingham and the East Midlands are meeting to hear how care and services in their region will be improved. Speaking at the meeting will be Kate Caston and Christine Richardson from the East Midlands NHS Specialised Commissioning Group... ...
read more Fri Mar 2010
William Hague Lends Muscle To Yorkshire And Humber Muscle Group, UK
Categorie : Muscular DystrophyA group of campaigning muscle disease patients from Yorkshire and Humber are proud to announce the Rt. Hon. William Hague MP as their new patron. The Yorkshire and Humber Muscle Group asked Mr Hague, as MP for Richmond and a Rotherham-born local lad, to be patron of their organisation and are pleas ...
read more Fri Mar 2010
ALS Therapy Development Institute And Oxford BioMedica Begin Second Phase Of Collaboration To Develop Gene Therapies For ALS, UK
Categorie : Muscular DystrophyThe ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase... ...
read more Wed Feb 2010
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrophy
Categorie : Muscular DystrophyAVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, announced that it received an orphan drug designation from the Committee for Orphan Medical Products of the European Medicines Agency (EMEA) for AVI-5038, a drug candidate being developed by AVI for the treatment of Duchenne Muscul ...
read more Wed Feb 2010
California Stem Cell And ALS Therapy Development Institute Extend Their Collaboration To Advance Potential Stem Cell Assisted Therapy For ALS
Categorie : Muscular DystrophyCalifornia Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis)... ...
read more Wed Feb 2010
Researchers Report That Tβ4 Increases Skeletal Muscle And May Have A Role In The Treatment Of Duchenne Muscular Dystrophy
Categorie : Muscular DystrophyRegenerx Biopharmaceuticals, Inc. (NYSE Amex:RGN) announced today that a research team in Washington, D.C. has found that dystrophin-deficient Mdx mice, treated twice a week for six months with Tβ4, showed a significant increase in skeletal muscle regenerating fibers compared to untreated mice. N ...
read more Wed Feb 2010
University Of Florida Researchers Continue 'Extraordinary Measures' To Tackle Pompe Disease
Categorie : Muscular DystrophyAs scientists work to find new treatments for Pompe disease - the devastating genetic "villain" that drives the efforts of the main characters in the new film "Extraordinary Measures" - University of Florida researchers are hopeful that gene therapy will help patients in the late stages of the disea ...
read more Thu Jan 2010
PTC Therapeutics Announces Additional Study Of Ataluren In Patients With Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy
Categorie : Muscular DystrophyPTC Therapeutics, Inc. (PTC) announced the initiation of an additional clinical trial of ataluren (PTC124®) in boys and young men with nonsense mutation Duchenne/Becker muscular dystrophy (nmDBMD) who have permanently lost the ability to walk independently. This trial is evaluating the best method ...
read more Sun Jan 2010
'Jekyll And Hyde' Cell May Hold Key To Muscular Dystrophy, Fibrosis Treatment: UBC Research
Categorie : Muscular DystrophyA team of University of British Columbia researchers has identified fat-producing cells that possess "dual-personalities" and may further the development of treatments for muscle diseases such as muscular dystrophy and fibrosis. The team found a new type of fibro/adipogenic progenitors, or FAPs, tha ...
read more Sun Jan 2010
BioMarin Initiates Phase 1 Clinical Study Of BMN 195 For Duchenne Muscular Dystrophy
Categorie : Muscular DystrophyBioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that the first subject has initiated treatment in the Phase 1 clinical study of BMN 195, a small molecule utrophin upregulator, for the treatment of Duchenne muscular dystrohpy (DMD). Initial top-line results are expected in the third quarter of ...
read more Sun Jan 2010
New ALS Drug Slips Through Telling "Phase II" Clinical Trials
Categorie : Muscular DystrophyA drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening that comes with amyotrophic lateral sclerosis (ALS), scientists report after completing a Phase II clinical trial-an early, small-scale test to show if the drug works and continues to be safe... ...
read more Mon Jan 2010
Muscular Dystrophy Therapy Based On Tarantula-Venom To Be Advanced By UB Scientists' Biotech Company
Categorie : Muscular DystrophyUniversity at Buffalo biophysicists have found a protein in tarantula venom that shows promise as a potential therapy for muscular dystrophy (MD). They have formed a start-up biotech company in Buffalo -- Rose Pharmaceuticals -- to advance the drug to clinical trials... ...
read more Mon Jan 2010
Unusual Protein Modification Involved In Muscular Dystrophy, Cancer
Categorie : Muscular DystrophyWith the discovery of a new type of chemical modification on an important muscle protein, a University of Iowa study improves understanding of certain muscular dystrophies and could potentially lead to new treatments for the conditions. The findings, which appear in the Jan. 1, 2010, issue of the jo ...
read more Mon Jan 2010
Muscular Dystrophy Association Renews Partnership With ALS Therapy Development Institute To Develop New Treatments For Lou Gehrig's Disease
Categorie : Muscular DystrophyBuoyed by the extraordinary progress being made by the ALS Therapy Development Institute, the Muscular Dystrophy Association today announced a new milestone-driven grant of $2.5 million, adding to the $18 million MDA already has invested with ALS TDI -- the world's only non-profit research center fo ...
read more Mon Jan 2010
Heavy Metal Paradox Could Point Toward New Therapy For Lou Gehrig's Disease
Categorie : Muscular DystrophyNew discoveries have been made about how an elevated level of lead, which is a neurotoxic heavy metal, can slow the progression of amyotrophic lateral sclerosis, or Lou Gehrig's disease - findings that could point the way to a new type of therapy. The results surprised researchers, since lead is al ...
read more Thu Dec 2009
Muscular Dystrophy Research Jeopordized By Mouse Model
Categorie : Muscular DystrophyHumans and mice have previously unknown and potentially critical differences in one of the genes responsible for Duchenne muscular dystrophy (DMD)... ...
read more Thu Dec 2009
CytRx Announces That FDA Lifts Clinical Hold Of Arimoclomol In ALS
Categorie : Muscular DystrophyCytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the U.S. Food and Drug A ...
read more Thu Dec 2009
A Cell's 'Cap' Of Bundled Fibers Could Yield Clues To Disease
Categorie : Muscular DystrophyIt turns out that wearing a cap is good for you, at least if you are a mammal cell. Researchers from the Johns Hopkins Engineering in Oncology Center have shown that in healthy cells, a bundled "cap" of thread-like fibers holds the cell's nucleus, its genetic storehouse, in its proper place... ...
read more Thu Dec 2009
